0001562180-22-000232.txt : 20220105 0001562180-22-000232.hdr.sgml : 20220105 20220105160651 ACCESSION NUMBER: 0001562180-22-000232 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220103 FILED AS OF DATE: 20220105 DATE AS OF CHANGE: 20220105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CRANDELL KEITH CENTRAL INDEX KEY: 0001219039 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38319 FILM NUMBER: 22511164 MAIL ADDRESS: STREET 1: 8755 W. HIGGINS ROAD STREET 2: SUITE 1025 CITY: CHICAGO STATE: IL ZIP: 60631 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quanterix Corp CENTRAL INDEX KEY: 0001503274 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 208957988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 MIDDLESEX TURNPIKE CITY: BILLERICA STATE: MA ZIP: 01821 BUSINESS PHONE: 617-301-9400 MAIL ADDRESS: STREET 1: 900 MIDDLESEX TURNPIKE CITY: BILLERICA STATE: MA ZIP: 01821 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-01-03 false 0001503274 Quanterix Corp QTRX 0001219039 CRANDELL KEITH 8755 WEST HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 true false true false Common Stock 2021-11-16 4 J false 189311.00 0.00 D 177247.00 I See footnote Common Stock 2021-11-16 4 J false 120689.00 0.00 D 113003.00 I See Footnote Common Stock 2021-11-16 4 J false 9952.00 0.00 A 105964.00 D Common Stock 2021-11-18 4 J false 177247.00 0.00 D 0.00 I See footnote Common Stock 2021-11-18 4 J false 113003.00 0.00 D 0.00 I See Footnote Common Stock 2021-11-18 4 J false 9318.00 0.00 A 115282.00 D Common Stock 2022-01-03 4 A false 2668.00 0.00 A 117950.00 D Common Stock 2022-01-03 4 A false 307.00 42.41 A 118257.00 D Stock Option (Right to Buy) 42.41 2022-01-03 4 A false 4002.00 0.00 A 2022-12-31 2032-01-03 Common Stock 4002.00 4002.00 D Distribution of Common Stock held by a limited partnership to its partners for no consideration. These shares are directly held by ARCH Venture Fund VI, L.P. ("ARCH VI"). ARCH Venture Partners VI, L.P. ("GPLP"), the sole general partner of ARCH VI, may be deemed to beneficially own the shares held by ARCH VI. ARCH Venture Partners VI, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person is a managing director of the GPLLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. These shares are directly held by ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"). ARCH Venture Partners VIII, LLC ("ARCH VIII LLC") the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person is a managing director of the ARCH VIII LLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person. Represents restricted stock units that vest as to 100% of the shares on December 31, 2022 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. Includes 2,668 restricted stock units. Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2021. Closing price of the Company's common stock on the Nasdaq Global Market on January 3, 2021. Represents non-qualified stock option to purchase 4,002 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. /s/ Brian Keane, as Attorney-in-Fact for Keith L. Crandell 2022-01-05